The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy
Sign Up to like & getrecommendations! Published in 2024 at "Oncotarget"
DOI: 10.18632/oncotarget.28607
Abstract: The growing understanding of the tumor immune microenvironment and its significance in shaping treatment outcomes has directed the latest advances in cancer therapy to boost antitumor immune responses. read more here.
Keywords: eat axis; therapy; advances targeting; sirp eat ... See more keywords